Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...
Novo Nordisk has announced plans to move its ziltivekimab into phase 3 clinical development in atherosclerosis with chronic kidney disease after a mid-stage trial met its main goal. The Danish pharma ...
Abstract: Three-stage synchronous generator (TSG) is extensively used in high-power transportation systems within the domain of transportation electrification. The multi-level generator structure and ...
The aircraft electrification, such as electric vertical takeoff and landing (eVTOL) technology has become ever-grown popular in commercial aircraft transport with the target of NetZero [1] [2]. In the ...